Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
Why Hims & Hers Health Stock Is Plummeting Today
Hims & Hers, one of the most popular telehealth services in the world, is in danger of losing one of its central revenue sources. The U.S. Food and Drug Administration (FDA) removed semaglutide ...
Cramer's week ahead: Earnings from Nvidia, Dell and Home Depot
CNBC's Jim Cramer walked investors through next week on Wall Street and highlighted earnings reports from Home Depot as well as tech giants Nvidia and Dell. He also discussed the market's decline over ...
Map Reveals How Obesity Rates in the U.S Compares to Europe
Data from the World Population Review for the U.S. and the World Health Organization for Europe reveal that America continues to struggle with significantly higher obesity rates w ...
Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
People are microdosing Ozempic, aka GLP-1, in the name of wellness. We asked experts to weigh in on the benefits
Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...
It finally happened.
According to the FDA, there is no longer a shortage of semaglutide, the active ingredient in the wildly popular Ozempic and Wegovy — a very bad omen for the countless telehealth and pharmacy ...